Sunshine Biopharma Inc. (SBFM)
NASDAQ: SBFM
· Real-Time Price · USD
2.20
0.27 (13.99%)
At close: Oct 16, 2025, 3:59 PM
2.08
-5.45%
After-hours: Oct 16, 2025, 07:59 PM EDT
13.99% (1D)
| Bid | 2.14 |
| Market Cap | 10.02M |
| Revenue (ttm) | 36.34M |
| Net Income (ttm) | -6.31M |
| EPS (ttm) | -15.02 |
| PE Ratio (ttm) | -0.15 |
| Forward PE | 5.45 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.33 |
| Volume | 28,329,300 |
| Avg. Volume (20D) | 80,589 |
| Open | 2.26 |
| Previous Close | 1.93 |
| Day's Range | 2.05 - 2.43 |
| 52-Week Range | 1.17 - 3.90 |
| Beta | 0.33 |
| Ex-Dividend Date | n/a |
About SBFM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SBFM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SBFM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsSunshine Biopharma Inc. is scheduled to release its earnings on
Nov 4, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
11 hours ago
Sunshine Biopharma shares are trading higher after...
Unlock content with
Pro Subscription
5 months ago
+3.2%
Sunshine Biopharma shares are trading higher after the company announced the launch of its oncology drug Everolimus in Canada.
19 hours ago · accessnewswire.com
Sunshine Biopharma Launches Cholesterol Fighting Medicine PravastatinFORT LAUDERDALE, FL / ACCESS Newswire / October 16, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety o...
